Litigation Details for Gilead Sciences, Inc. v. Apotex Inc. (D. Del. 2022)
✉ Email this page to a colleague
Gilead Sciences, Inc. v. Apotex Inc. (D. Del. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-10-25 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Patents | 10,039,718 | ||
| Link to Docket | External link to docket | ||
Details for Gilead Sciences, Inc. v. Apotex Inc. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-10-25 | 1 | Complaint | U.S. Patent No. 10,039,718 (the “’718 patent”) and U.S. Patent No. 10,786,518 (the “’518 patent”) (together…expiration of the ’718 patent, ’518 patent, ’396 patent, ’473 patent, and ’100 patent (including such actions…infringement of the ’718 patent, ’518 patent, ’396 patent, ’473 patent, and ’100 patent under 35 U.S.C. §§ …expiration date of the ’718 patent, ’518 patent, ’396 patent, ’473 patent, and ’100 patent including any extensions…claims of the ’718 patent, ’518 patent, ’396 patent, ’473 patent, and ’100 patent; E) A | External link to document |
| 2023-02-28 | 23 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,039,718; 9,428,473; 9,115,… 25 October 2022 1:22-cv-01399 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2022-10-25 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,039,718 B2 ;10,786,518 B2 … 25 October 2022 1:22-cv-01399 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
